HIMS Stock Snaps 3-Day Losing Streak: FDA Adds 8 New Peptide Voters Deemed ‘More Qualified And Less Conflicted’
Shares of Hims & Hers Health, Inc. (HIMS) stock rebounded on Tuesday after the FDA expanded its peptide advisory panel with eight new voting members ahead of a crucial review of seven unapproved compounds.HIMS stock rose a modest 0.1% on Tuesday, with shares headed for their worst month since Febru…